🌍·15h agoResearch
Clinical Impact of PCSK9 Inhibitor Discontinuation on Cardiovascular Outcomes ― Real-World Evidence From the Kyoto PCSK9 Registry ―
Publisher
C
Crossref
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Crossref
- Region
- Global
- Scope
- Research
- Published
- July 11, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on doi.org
Leave the platform to read the original full article on the publisher site.
Source: Crossref
Scope: Research
Related coverage
More related coverage
Crossref/15h ago
Anatomical Study of the Triangle of Brocq and Mouchet and Its Clinical Implications for Coronary Interventions in Human Cadaveric Hearts
Crossref/15h ago
Potential Drug Interactions of Antidiabetic Agents in Geriatric Patients with Type 2 Diabetes Mellitus at the Inpatient Unit of a Hospital in Bandung City
Crossref/15h ago
Assessment of Hepatitis E Virus Seroprevalence in Patients Presenting with Suspected Acute Viral Hepatitis
Crossref/15h ago